Clinical Trial Update: Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing lidocaine-prilocaine (EMLA) cream for analgesia during hysterosalpingography. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Pathology

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)

Snippet

Sponsor: Consorci Sanitari de Terrassa | Conditions: Gynecological Pathology | Phase 4 | Status: UNKNOWN